Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3)

Abstract

The human concentrative nucleoside transporter, CNT3 (SLC28A3), plays an important role in mediating the cellular entry of a broad array of physiological nucleosides and synthetic anticancer nucleoside analog drugs. As a first step toward understanding the genetic basis for interindividual differences in the disposition and response to antileukemic nucleoside analogs, we examined the genetic and functional diversity of CNT3. In all, 56 variable sites in the exons and flanking intronic region of SLC28A3 were identified in a collection of 270 DNA samples from US populations (80 African-Americans, 80 European-Americans, 60 Asian-Americans, and 50 Mexican-Americans). Of the 16 coding region variants, 12 had not been previously reported. Also, 10 resulted in amino-acid changes and three of these had total allele frequencies of ≥1%. Nucleotide diversity (π) at nonsynonymous and synonymous sites was estimated to be 1.81 × 104 and 18.13 × 104, respectively, suggesting that SLC28A3 is under negative selection. All nonsynonymous variants, constructed by site-directed mutagenesis and expressed in Xenopus laevis oocytes, transported purine and pyrimidine model substrates, except for c. 1099G>A (p. Gly367Arg). This rare variant alters an evolutionarily conserved site in the putative substrate recognition domain of CNT3. The presence of three additional evolutionarily conserved glycine residues in the vicinity of p. Gly367Arg that are also conserved in human paralogs suggest that these glycine residues are critical in the function of the concentrative nucleoside transporter family. The genetic analysis and functional characterization of CNT3 variants suggest that this transporter does not tolerate nonsynonymous changes and is important for human fitness.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Baldwin SA, Mackey JR, Cass CE, Young JD . Nucleoside transporters: molecular biology and implications for therapeutic development. Mol Med Today 1999; 5: 216–224.

    Article  CAS  PubMed  Google Scholar 

  2. Ritzel MW, Ng AM, Yao SY, Graham K, Loewen SK, Smith KM et al. Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol Chem 2001; 276: 2914–2927.

    Article  CAS  PubMed  Google Scholar 

  3. Mangravite LM, Badagnani I, Giacomini KM . Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney. Eur J Pharmacol 2003; 479: 269–281.

    Article  CAS  PubMed  Google Scholar 

  4. Pott C, Hiddemann W . Purine analogs in the treatment of chronic lymphocytic leukemia. Leukemia 1997; 11: S25–S28.

    PubMed  Google Scholar 

  5. Robak T . The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia–lessons learned from prospective randomized trials. Leuk Lymphoma 2002; 43: 537–548.

    Article  CAS  PubMed  Google Scholar 

  6. Molina-Arcas M, Bellosillo B, Casado FJ, Montserrat E, Gil J, Colomer D et al. Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia. Blood 2003; 101: 2328–2334.

    Article  CAS  PubMed  Google Scholar 

  7. Gray JH, Mangravite LM, Owen RP, Urban TJ, Chan W, Carlson EJ et al. Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations. Mol Pharmacol 2004; 65: 512–519.

    Article  CAS  PubMed  Google Scholar 

  8. Leabman MK, Huang CC, DeYoung J, Carlson EJ, Taylor TR, de la Cruz M et al. Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci USA 2003; 100: 5896–5901.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Stephens M, Smith NJ, Donnelly P . A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978–989.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Nebert DW . Proposal for an allele nomenclature system based on the evolutionary divergence of haplotypes. Hum Mutat 2002; 20: 463–472.

    Article  CAS  PubMed  Google Scholar 

  11. Grantham R . Amino acid difference formula to help explain protein evolution. Science 1974; 185: 862–864.

    Article  CAS  PubMed  Google Scholar 

  12. Wang J, Giacomini KM . Molecular determinants of substrate selectivity in Na+-dependent nucleoside transporters. J Biol Chem 1997; 272: 28845–28848.

    Article  CAS  PubMed  Google Scholar 

  13. Fay JC, Wyckoff GJ, Wu CI . Positive and negative selection on the human genome. Genetics 2001; 158: 1227–1234.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Gray JH, Owen RP, Giacomini KM . The concentrative nucleoside transporter family, SLC28. Pflugers Arch 2004; 447: 728–734.

    Article  CAS  PubMed  Google Scholar 

  15. Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE et al. Haplotype variation and linkage disequilibrium in 313 human genes. Science 2001; 293: 489–493.

    Article  CAS  PubMed  Google Scholar 

  16. Miller MP, Kumar S . Understanding human disease mutations through the use of interspecific genetic variation. Hum Mol Genet 2001; 10: 2319–2328.

    Article  CAS  PubMed  Google Scholar 

  17. Shu Y, Leabman MK, Feng B, Mangravite LM, Huang CC, Stryke D et al. Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci USA 2003; 100: 5902–5907.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Vitkup D, Sander C, Church GM . The amino-acid mutational spectrum of human genetic disease. Genome Biol 2003; 4: R72.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Majewski J, Ott J . Amino acid substitutions in the human genome: evolutionary implications of single nucleotide polymorphisms. Gene 2003; 305: 167–173.

    Article  CAS  PubMed  Google Scholar 

  20. Wang Z, Moult J . SNPs, protein structure, and disease. Hum Mutat 2001; 17: 263–270.

    Article  PubMed  Google Scholar 

  21. Partridge AW, Therien AG, Deber CM . Polar mutations in membrane proteins as a biophysical basis for disease. Biopolymers 2002; 66: 350–358.

    Article  CAS  PubMed  Google Scholar 

  22. Russ WP, Engelman DM . The GxxxG motif: a framework for transmembrane helix–helix association. J Mol Biol 2000; 296: 911–919.

    Article  CAS  PubMed  Google Scholar 

  23. Osato DH, Huang CC, Kawamoto M, Johns SJ, Stryke D, Wang J et al. Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1. Pharmacogenetics 2003; 13: 297–301.

    Article  CAS  PubMed  Google Scholar 

  24. Leabman MK, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE et al. Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. Pharmacogenetics 2002; 12: 395–405.

    Article  CAS  PubMed  Google Scholar 

  25. Toan SV, To KK, Leung GP, de Souza MO, Ward JL, Tse CM . Genomic organization and functional characterization of the human concentrative nucleoside transporter-3 isoform (hCNT3) expressed in mammalian cells. Pflugers Arch 2003; 447: 195–204.

    Article  CAS  PubMed  Google Scholar 

  26. Tajima F . Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 1989; 123: 585–595.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Hartl DL, Clark AG . Principles of Population Genetics, 3rd edn. Sunderland, MA: Sinauer Associates, 1997.

    Google Scholar 

  28. Zhang L, Schaner ME, Giacomini KM . Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa). J Pharmacol Exp Ther 1998; 286: 354–361.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Institute of Health (NIH) grants GM61390 and GM42230. IB was supported in part by a National Science Foundation Graduate Research Fellowship. The study was supported by the General Clinical Research Center at San Francisco General Hospital, funded by the National Center for Research Resources, National Institutes of Health (grant MO1-RR00083-42). We thank Jennifer Gray and Ryan Owen for their thoughtful advice and technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K M Giacomini.

Additional information

DUALITY OF INTEREST

None declared.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Badagnani, I., Chan, W., Castro, R. et al. Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3). Pharmacogenomics J 5, 157–165 (2005). https://doi.org/10.1038/sj.tpj.6500303

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500303

Keywords

This article is cited by

Search

Quick links